Ota, S., Matsukawa, T., Yamamoto, S., Ito, S., Shindo, M., Sato, K., Kondo, T., Kohda, K., Sakai, H., Mori, A., Takahashi, T., Ikeda, H., Kuroda, H., Haseyama, Y., Yamamoto, M., Sarashina, T., Yoshida, M., Kobayashi, R., Nishio, M., Ishihara, T., Hirayama, Y., Kakinoki, Y., Kobayashi, H., Fukuhara, T., Imamura, M., & Kurosawa, M. (2018). severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic‐phase chronic myeloid leukemia. European journal of haematology, 101, 95–105. http://access.bl.uk/ark:/81055/vdc_100066420328.0x000040